EMI and CIED: Is High Power Charging of Battery Electric Car Safe? (eCarII)

May 2, 2022 updated by: Deutsches Herzzentrum Muenchen

Assessment of Electromagnetic Interference Between Cardiac Implantable Electronic Devices and High Power Charging Systems for Battery Electric Cars

It is not known if the use of high power charging systems for electric vehicles may interfere with the functionality of implanted pacemakers and cardioverter-defibrillators.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

The use of electric cars for public and private transport is increasing all over the world. Moreover the charging technique is improving and enables very fast charging with the use of high power. It is not known if the use of high volume charging systems interfere with cardiac implantable electronic devices. The study evaluates different types of high volume charging systems connected to different full electric vehicles with regard to electromagnetic interference with implanted pacemakers or cardioverter-defibrillators.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bayern
      • Munich, Bayern, Germany, 80636
        • Deutsches Herzzentrum München

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • implanted cardiac implantable electronic device with regular function

Exclusion Criteria:

  • implanted cardiac implantable electronic device with irregular function

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: interventional arm
Participants were charging full electric cars, using high power charging systems
All participants were exposed to the electromagnetic field of 4-5 different high power charging systems, charging 4-5 different, commercially available full electric cars

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electromagnetic interference
Time Frame: during the intervention, i.e. when participants are exposed to the electromagnetic field of the high power charging column
Occurence of electromagnetic interference during an exposure time of up to 5 minutes
during the intervention, i.e. when participants are exposed to the electromagnetic field of the high power charging column

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electromagnetic fields
Time Frame: during the intervention
Measuring the electromagnetic fields while super-charging along the charging cable, the column and the car connector
during the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Anticipated)

July 1, 2022

Study Completion (Anticipated)

September 1, 2022

Study Registration Dates

First Submitted

August 31, 2021

First Submitted That Met QC Criteria

May 2, 2022

First Posted (Actual)

May 5, 2022

Study Record Updates

Last Update Posted (Actual)

May 5, 2022

Last Update Submitted That Met QC Criteria

May 2, 2022

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • GER-EP-024

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pacemaker

Clinical Trials on Electromagnetic Field Exposure

3
Subscribe